Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Study in the Second-Line Treatment of Advanced Hepatocellular Carcinoma in Subjects With Child-Pugh Class B Cirrhosis

NCT02128958 is registered in ClinicalTrials.gov with Can-Fite BioPharma as lead sponsor.

NCT NCT02128958
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02128958 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Study in the Second-Line Treatment of Advanced Hepatocellular Carcinoma in Subjects With Child-Pugh Class B Cirrhosis
Lead sponsor
Can-Fite BioPharma
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2014
Completion date
December 31, 2021
Enrollment
78 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma